Skip to main content

Abstract

Aim: To compare outcomes among patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing outpatient ventricular tachycardia (VT) catheter ablation using intracardiac echocardiography (ICE) versus no ICE. Patients & methods: Patients were classified into ICE (n = 1143)/non-ICE (n = 1677) groups based on ICE procedure codes. Patients in each group were propensity matched on study covariates. Survival analyses were used to assess outcomes. To examine residual confounding, falsification outcomes were evaluated. Results: ICE patients had a 24% lower risk of all-cause readmissions, 24% lower risk of cardiovascular-related and 20% lower risk of VT-related readmissions compared with non-ICE patients. Falsification analyses for ICE use association were nonsignificant. Conclusion: Patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing VT ablation with ICE use had significantly lower likelihood of VT-related readmission.

Supplementary Material

File (suppl_file.zip)
File (supplementary figure 1.tif)
File (supplementary material 1.docx)
File (supplementary table 1.docx)

References

Papers of special note have been highlighted as: • of interest
1.
Al-Khatib SM, Stevenson WG, Ackerman MJ et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 138(13), e272–e391 (2018).
2.
Reddy VY, Reynolds MR, Neuzil P et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N. Engl. J. Med. 357(26), 2657–2665 (2007).
3.
Kuck KH, Schaumann A, Eckardt L et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708), 31–40 (2010).
• This multicenter study shows that prophylactic catheter ablation before implantation of a cardioverter defibrillator may prolong time to recurrence of ventricular tachycardia (VT).
4.
Winterfield JR, Kent AR, Karst E et al. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm 15(3), 355–362 (2018).
• This retrospective study demonstrated that catheter ablation seems to reduce hospitalization and overall healthcare utilizations in VT patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator.
5.
Sapp JL, Wells GA, Parkash R et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N. Engl. J. Med. 375(2), 111–121 (2016).
• This randomized study shows that catheter ablation was associated with a significantly lower rate of death, VT storm or appropriate implantable cardioverter defibrillator shock among with ischemic cardiomyopathy and cardioverter defibrillator who were refrctory to antiarrythmic drug therapy.
6.
Jongbloed MR, Bax JJ, Van Der Burg AE, Van Der Wall EE, Schalij MJ. Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur. J. Echocardiogr. 5(1), 34–40 (2004).
7.
Bala R, Ren JF, Hutchinson MD et al. Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ. Arrhythm. Electrophysiol. 4(5), 667–673 (2011).
8.
Callans DJ, Ren JF, Michele J, Marchlinski FE, Dillon SM. Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis. Circulation 100(16), 1744–1750 (1999).
9.
Ren JF, Marchlinski FE. Early detection of iatrogenic pericardial effusion: importance of intracardiac echocardiography. JACC Cardiovasc. Interv. 3(1), 127 (2010).
10.
Enriquez A, Saenz LC, Rosso R et al. Use of intracardiac echocardiography in interventional cardiology: working with the anatomy rather than fighting it. Circulation 137(21), 2278–2294 (2018).
• This review article provides technical details about intracardiac echocardiography.
11.
Kalman JM, Fitzpatrick AP, Olgin JE et al. Biophysical characteristics of radiofrequency lesion formation in vivo: dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am. Heart J. 133(1), 8–18 (1997).
12.
Cronin EM, Bogun FM, Maury P et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 21(8), 1143–1144 (2019).
13.
Katz DF, Turakhia MP, Sauer WH et al. Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records. Circ. Arrhythm. Electrophysiol. 8(2), 362–370 (2015).
14.
Deshmukh A, Patel NJ, Pant S et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 128(19), 2104–2112 (2013).
15.
Prasad V, Jena AB. Prespecified falsification end points: can they validate true observational associations? JAMA 309(3), 241–242 (2013).
16.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45(6), 613–619 (1992).
17.
Quan H, Li B, Couris CM et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173(6), 676–682 (2011).
18.
Vitulano N, Pazzano V, Pelargonio G, Narducci ML. Technology update: intracardiac echocardiography – a review of the literature. Med. Devices (Auckl.) 8, 231–239 (2015).
19.
Steinberg BA, Hammill BG, Daubert JP et al. Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation. Heart 100(23), 1871–1877 (2014).
20.
Filgueiras-Rama D, De Torres-Alba F, Castrejon-Castrejon S et al. Utility of intracardiac echocardiography for catheter ablation of complex cardiac arrhythmias in a medium-volume training center. Echocardiography 32(4), 660–670 (2015).
• A prospective study that shows that use of intracardiac echocardiography during abalation of complex cardiac substrate may decrease complications and increase accuracy.
21.
Sharma PS, Padala SK, Gunda S, Koneru JN, Ellenbogen KA. Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J. Cardiovasc. Electrophysiol. 27(10), 1160–1166 (2016).
22.
Pluta S, Lenarczyk R, Pruszkowska-Skrzep P et al. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm. J. Intervent. Cardiac Electrophysiol. 28(1), 45–50 (2010).